| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159435 | The Journal of Urology | 2012 | 6 Pages |
Abstract
Adjusting for risk factors, overall survival was significantly improved in the post-prostate specific antigen era trial. However, it cannot be concluded that this was attributable only to prostate specific antigen monitoring. Black men now have overall survival comparable to that of white men. Current estimates of survival should be used to design new trials in this population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Catherine M. Tangen, Maha H.A. Hussain, Celestia S. Higano, Mario A. Eisenberger, Eric J. Small, George Wilding, Bryan J. Donnelly, Paul F. Schelhammer, E. David Crawford, Nicholas J. Vogelzang, Isaac J. Powell, Ian M. Jr.,